Bioverativ
Get Full AccessDescription
- Bioverativ is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders. We have a leading portfolio of hemophilia therapies and an innovative pipeline of programs in hemophilia, sickle cell disease and beta thalassemia. We believe that great science conquers the toughest medical obstacles, and we are inspired to push scientific boundaries to make a meaningful impact in the lives of people with rare blood disorders. As an independent company formed by a spin-off of Biogens hemophilia business in 2017, we bring a strong legacy of innovation, world-class science, and commitment to the blood disorders community. We are united by a singular purpose: to create progress where patients need it most. With nearly 400 people and robust capabilities from discovery to commercialization, our vision is to become the leading hematology rare disease company.
-
Headquarters:225 2nd Avenue , Waltham, Massachusetts, United States
More -
Phone Number: +1 781-663-4400
-
Website: https://www.bioverativ.com
-
Employees:281
-
Revenue:$250 - 500M
-
Legal Name:Bioverativ
-
Bioverativ's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
View Employees
Frequently Asked Questions regarding Bioverativ
-
Where are Bioverativ's Headquarters?
Bioverativ's Headquarters are in 225 2nd Avenue ,Waltham,Massachusetts,United States
-
What is Bioverativ's phone number?
Bioverativ's phone number is +1 781-663-4400
-
What is Bioverativ's official website?
Bioverativ's official website is https://www.bioverativ.com
-
What is Bioverativ's Revenue?
Bioverativ's revenue is $250 - 500M
-
What is Bioverativ's NAICS code?
Bioverativ's NAICS code is 541713
-
How many employees are working in Bioverativ
Bioverativ has 281 employees
-
What is Bioverativ's Industry?
Bioverativ is in the industry of Biotechnology
-
Who is Bioverativ's Vice President And Chief Information Officer?
Bioverativ's Vice President And Chief Information Officer is Ravi Narasimhan

